Skip to content
FindTrial
Search trials
Search trials by condition, treatment, sponsor...
Sign In
Benicar HCT ® Tablets 40 mg/25 mg
DRUG
2 trials
Sponsors
Mylan Pharmaceuticals Inc
, Eurofarma Laboratorios S.A.
Conditions
Essential Arterial Hypertension
Healthy
Phase 1
Fed Study of Olmesartan Medoxomil and Hydrochlorothiazide Tablets 40 mg/25 mg and Benicar HCT® Tablets 40 mg/25 mg
Completed
NCT01019590
Mylan Pharmaceuticals Inc
Healthy
Start: 2006-11-30
End: 2006-11-30
Updated: 2024-04-23
Phase 3
Fixed-dose Combination of an Angiotensin Receptor Blocker and Thiazide Diuretic for Essential Hypertension
Not yet recruiting
NCT06608472
Eurofarma Laboratorios S.A.
Essential Arterial Hypertension
Start: 2026-11-30
End: 2029-10-30
Target: 292
Updated: 2024-11-27